A
AlloVir
ALVR
0.80000
USD
0.07
(9.59%)
مفتوح الان
حجم التداول
19,018
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
110,739,134
العنوان: AlloVir
القطاع: Healthcare
الصناعة: Biotechnology
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.